← TrialMatch
HomeTrials

Water Exchange and CO2 Insufflation With Abdominal Compression Device to Reduce Manual Ass

The goal of this trial is to evaluate whether water exchange colonoscopy and CO2-insufflation colonoscopy with an abdominal compression device (Maxbelt me3 type, Nippon Sigmax Co., Tokyo, Japan) can achieve a significantly lower proportion of patients requiring manual abdominal pressure during colonoscopic insertion co

Condition(s)Manual Pressure, Repositioning, Colonoscopy, Colon Polyp
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe goal of this trial is to evaluate whether water exchange colonoscopy and CO2-insufflation colonoscopy with an abdominal compression device (Maxbelt me3 type, Nippon Sigmax Co., Tokyo, Japan) can achieve a significantly lower proportion of patients requiring manual abdominal pressure during colonoscopic insertion compared with CO2 insufflation alone.
Who can participateInclusion Criteria: * Patients aged 45-80 years having an average risk for colorectal cancer who plan to undergo sedated outpatient colonoscopy for screening, surveillance, and those who have received a positive fecal immunochemical test result Exclusion Criteria: * Patients with hereditary colorectal cancer syndrome, including familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer (Lynch syndrome) * Patients with serrated polyposis syndrome * Patients with known or suspected inflammatory bowel disease * Patients with a history of colorectal cancer or other intra-abdominal malignancy * Patients with a history of colorectal resection * Patients with a history of abdominal aortic aneurysm, cirrhosis, ascites, or other severe comorbid illnesses * Patients with recent wou
Ages45 Years to 80 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorEvergreen General Hospital, Taiwan
LocationsKaohsiung City, Taiwan; Taoyuan, Taiwan
Start date2024-09-02
NCT IDNCT06496958
Official listinghttps://clinicaltrials.gov/study/NCT06496958

🔍 Search all trials →